|
|
Volumn 15, Issue 13, 2009, Pages 4256-4262
|
|
Multiple histology phase II trials
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PLATELET DERIVED GROWTH FACTOR RECEPTOR;
SORAFENIB;
VASCULOTROPIN RECEPTOR;
ANGIOSARCOMA;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CLASSIFICATION;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG TARGETING;
HEMANGIOPERICYTOMA;
HISTOPATHOLOGY;
HUMAN;
HYPOTHESIS;
INFORMATION PROCESSING;
LEIOMYOSARCOMA;
LIPOSARCOMA;
MATHEMATICAL ANALYSIS;
METHODOLOGY;
OUTCOME ASSESSMENT;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROBABILITY;
PROGNOSIS;
PROTEIN EXPRESSION;
SAMPLE SIZE;
SEQUENTIAL ANALYSIS;
SIMULATION;
SOFT TISSUE SARCOMA;
STATISTICAL ANALYSIS;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CLINICAL TRIALS, PHASE II AS TOPIC;
COMPUTER SIMULATION;
HUMANS;
NEOPLASM STAGING;
NEOPLASMS;
PYRIDINES;
RESEARCH DESIGN;
SARCOMA;
TREATMENT OUTCOME;
|
|
EID: 67650345287
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: 10.1158/1078-0432.CCR-08-2069 Document Type: Article |
|
Times cited : (30)
|
|
References (6)
|
